WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
WX was delisted on the 10th of December, 2015.
2 hedge funds and large institutions have $69K invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 148 closing their positions.
99% less funds holding
Funds holding: 151 → 2 (-149)
99% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 148
100% less funds holding in top 10
Funds holding in top 10: 14 → 0 (-14)
100% less capital invested
Capital invested by funds: $2.42B → $69K (-$2.42B)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCS
Crosspoint Capital Strategies
Orinda,
California
|
+$2.83K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
-$273M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$229M |
| 3 |
O
OppenheimerFunds
New York
|
-$171M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$148M |
| 5 |
MICM
Matthews International Capital Management
San Francisco,
California
|
-$116M |
WX Hedge Fund Activity: Q4 2015 in Review
2 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q4 2015, worth a combined $69K — down 100% from $2.42B a quarter earlier.
Sellers outnumbered buyers: 148 funds closed out of WX and 1 opened new positions — a net loss of 147 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Crosspoint Capital Strategies, opening a new position worth an estimated $2.83K. The largest seller was Schroder Investment Management Group, exiting entirely with an estimated $273M sold.
- 2 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q4 2015, down from 151 in Q3 2015.
- Funds reported $69K of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q4 2015, down 100% quarter-over-quarter.
- 1 fund opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q4 2015 and 148 closed out, a net change of -147 holders.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q4 2015 was Crosspoint Capital Strategies, an estimated $2.83K added.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q4 2015 was Schroder Investment Management Group, an estimated $273M sold.
Based on aggregated 13F filings for Q4 2015.